Progestatifs et risque de méningiome : renforcement des conditions de prescription et de délivrance de Depo Provera 150 mg/3 mL et Colprone 5 mg (ANSM - 28/06/2024)
Powered by
eZ Publish™ CMS Open Source Web Content Management
. Copyright © 1999-2014
eZ Systems AS
(except where otherwise noted). All rights reserved.